A synthetic peptide for use as a blocking control in assays to test for specificity of FANCL antibody, Alternative Names: FANCL control peptide, FANCL antibody Blocking Peptide, Anti-FANCL Blocking Peptide, Fanconi Anemia Complementation Group L Blocking Peptide, FAAP43 Blocking Peptide, FLJ10335 Blocking Peptide, PHF9 Blocking Peptide, POG Blocking Peptide
Optimal conditions should be determined by the investigator
限制
仅限研究用
状态
Lyophilized
溶解方式
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
缓冲液
PBS
注意事项
Avoid repeated freeze/thaw cycles.
储存条件
-20 °C
储存方法
Store at -20 °C long term.
抗原
FANCL
(Fanconi Anemia, Complementation Group L (FANCL))
别名
FAAP43 Peptide, PHF9 Peptide, POG Peptide, 2010322C19Rik Peptide, AW554273 Peptide, B230118H11Rik Peptide, Phf9 Peptide, Pog Peptide, gcd Peptide, Fanconi anemia complementation group L Peptide, Fanconi anemia, complementation group L Peptide, FANCL Peptide, Fancl Peptide
背景
The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ, FANCL, FANCM and FANCN. The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair.